Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Block

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Gynecologic Oncology|May 3, 2017
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancersGerardo Colon-Otero, S John Weroha, Nathan R Foster, et al.
JCO Clinical Cancer Informatics|April 30, 2024
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language ProcessingHannah Barman, Sriram Venkateswaran, Antonio Del Santo, et al.
Oncogene|August 7, 2023
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interactionUpasana Ray, Prabhu Thirusangu, Ling Jin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 2, 2024
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor UseStephanie B Syc-Mazurek, Hannah Zhao-Fleming, Yong Guo, et al.
Melanoma Research|May 15, 2020
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patientsJesus Vera Aguilera, Jonas Paludo, Robert R McWilliams, et al.
Journal of Surgical Oncology|July 9, 2022
Merkel cell carcinoma of unknown primary: Clinical presentation and outcomesSamuel E Broida, Xiao T Chen, Christian L Baum, et al.
Immunotherapy|September 15, 2011
The dynamic human immune response to cancer: it might just be rocket scienceShernan G Holtan, Roxana S Dronca, Wendy K Nevala, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2015
Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patientsSara J Felts, Virginia P Van Keulen, Adam D Scheid, et al.
Immunotherapy|August 6, 2020
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanomaEric P Grewal, Courtney L Erskine, Wendy K Nevala, et al.
Gynecologic Oncology|December 21, 2020
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancerAllyson C Banville, Maartje C A Wouters, Ann L Oberg, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology|May 3, 2017
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancersGerardo Colon-Otero, S John Weroha, Nathan R Foster, et al.
JCO Clinical Cancer Informatics|April 30, 2024
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language ProcessingHannah Barman, Sriram Venkateswaran, Antonio Del Santo, et al.
Oncogene|August 7, 2023
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interactionUpasana Ray, Prabhu Thirusangu, Ling Jin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 2, 2024
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor UseStephanie B Syc-Mazurek, Hannah Zhao-Fleming, Yong Guo, et al.
Melanoma Research|May 15, 2020
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patientsJesus Vera Aguilera, Jonas Paludo, Robert R McWilliams, et al.
Journal of Surgical Oncology|July 9, 2022
Merkel cell carcinoma of unknown primary: Clinical presentation and outcomesSamuel E Broida, Xiao T Chen, Christian L Baum, et al.
Immunotherapy|September 15, 2011
The dynamic human immune response to cancer: it might just be rocket scienceShernan G Holtan, Roxana S Dronca, Wendy K Nevala, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2015
Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patientsSara J Felts, Virginia P Van Keulen, Adam D Scheid, et al.
Immunotherapy|August 6, 2020
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanomaEric P Grewal, Courtney L Erskine, Wendy K Nevala, et al.
Gynecologic Oncology|December 21, 2020
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancerAllyson C Banville, Maartje C A Wouters, Ann L Oberg, et al.
Pageof 12